0% found this document useful (0 votes)
33 views7 pages

GTK24092812-pages 3

Uploaded by

wmgx26g5f7
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
33 views7 pages

GTK24092812-pages 3

Uploaded by

wmgx26g5f7
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 7

Patient Name : Ashish Chadha Lab No : GTK24092812

Age / Sex : 45 Y / M Registration On : 22-Sep-24 16:28


Referred By : Dr. JAGDEEP CHUGH Patient ID : UGTK.0000011692
Centre : ASHOK VIHAR
-----------------------------------------------------------------------------------------------------------------
Clinical Significance of LFT:e clinical suspicion of liver disease usually leads to the measurement of the liver function tests (LFT) which include measurement of several enzymes,
serum bilirubin and albumin. These parameters may point to an underlying pathological process and direct further investigation. The aim of investigation in patients with suspected
liver disease are: ·To detect hepatic abnormality · Measurement of severity of liver damage · Identify the specific cause ·Investigate possible complications
---------------------------------------------------------------------------------
Technology: Dry Chemistry (VITROS MicroSlide, MicroSensor and Intellicheck Technology)
Analyzer:Fully Automated Biochemistry and ImmunoAssay Analyzer: VITROS 5600
---------------------------------------------------------------------------------
Advise:Please correlate results clinically.
---------------------------------------------------------------------------------

In case of any unexpected or alarming results, please contact us immediately for re-confirmation, clarifications, and rectifications, if needed.

Scan to Validate

Page 3 of 8
B-52, Basement and Ground Floor, GT Karnal Road, Industrial Area, Delhi 110033
Patient Name : Ashish Chadha Lab No : GTK24092812
Age / Sex : 45 Y / M Registration On : 22-Sep-24 16:28
Referred By : Dr. JAGDEEP CHUGH Patient ID : UGTK.0000011692
Centre : ASHOK VIHAR

CBC EDTA Whole Blood Sample

Accession No: ED01091352 Collected On: 22-Sep-24 16:28 Received On: 22-Sep-24 19:30 Approved On: 22-Sep-24 21:02

Observation Result Unit Biological Ref. Interval Method


Hemoglobin 14.5 gm/dL 13.0 - 17.0 Photometric Measurement
Total RBC 4.55 million/µL 4.5 - 5.5 Coulter Principle
Platelet Count 165 X 10³ / µL 150 - 410 x 10³/µL Impedance
Total Leucocyte Count (WBC) 4.57 X 10³ / µL 4.0 - 10.0 Flow Cytometry
Differential Leucocyte Count (DLC)

Neutrophils 66.2 % 40 - 80 Flow Cytometry


Lymphocytes 20.0 % 20 - 40 Flow Cytometry
Monocytes 4.7 % 2 - 10 Flow Cytometry
Eosinophils 8.7 % 1-6 Flow Cytometry
Basophils 0.4 % 0-1 Flow Cytometry

Absolute Neutrophil Count 3.03 X 10³ / µL 2.0 - 7.5 Flow Cytometry


Absolute Lymphocyte Count 0.91 X10³ / µL 1.0 - 4.0 Flow Cytometry
Absolute Monocyte Count 0.21 X 10³ / µL 0.2 - 1.0 Flow Cytometry
Absolute Eosinophil Count 0.4 X 10³ / µL 0.02 - 0.5 Flow Cytometry
Absolute Basophil Count 0.03 X10³ / µL 0.00 - 0.30 Flow Cytometry
Indices
Hematocrit (PCV) 44.0 % 40 - 50 Calculated
Mean Corpuscular Volume (MCV) 96.5 fL 83 - 101 Calculated

Mean Corp. Hemoglobin (MCH) 31.8 pg 27 - 32 Calculated


MCH Concentration (MCHC) 33.0 g/dl 31.5 - 34.5 Calculated
Red Cell Dist. Width (RDW-CV) 12.8 % 11.5 - 14.5 Calculated
Red Cell Dist. Width (RDW-SD) 48.8 fL 39 - 46 Calculated
Mean Platelet Volume (MPV) 12.5 fL 7-5 - 12.0 Calculated
P-LCC 71 10^9/L 30-90 SF Cube
P-LCR 43.03 % 11-45 Calculated
Neutrophil-Lymphocyte Ratio (NLR) 3.31 Ratio Calculated
Mentzer Index 21.21 Index Calculated

-----------------------------------------------------------------------------------------------------------------
Remarks: Please correlate with clinical conditions
-----------------------------------------------------------------------------------------------------------------

Scan to Validate

Page 4 of 8
B-52, Basement and Ground Floor, GT Karnal Road, Industrial Area, Delhi 110033
Patient Name : Ashish Chadha Lab No : GTK24092812
Age / Sex : 45 Y / M Registration On : 22-Sep-24 16:28
Referred By : Dr. JAGDEEP CHUGH Patient ID : UGTK.0000011692
Centre : ASHOK VIHAR

Urine R/M Urine Sample

Accession No: CP00500094 Collected On: 22-Sep-24 16:28 Received On: 22-Sep-24 19:30 Approved On: 22-Sep-24 20:17

Observation Result Unit Biological Ref. Interval Method


Physical Examination
Urine Quantity 7.5 mL 7-8 Physical Examination
Urine Colour Pale Yellow Pale Yellow Physical Examination
Urinary Transparency Clear Clear Physical Examination
Biochemical Examination
Urinary pH 6.0 pH 6 .0 - 8.0 pH bromothymol blue
Urinary Specific Gravity 1.005 1.005 - 1.030 Ethyleneglycol-bis t.a.a.

Urinary Protein Negative Negative Tetrachlorophenol


Urinary Glucose Negative Negative glucose-oxidase-peroxidase
Urinary Ketones Negative Negative Sodium Nitroprusside
Urobilinogen Negative Negative Methoxybenzene Diazonium
Urine Bilirubin Negative Negative Dichlorobenzene-diazonium
Urinary Nitrites Negative Negative hydroxy
Blood [In Urine] Negative Negative Tetramethylbenzidine
Leukocyte esterase Negative Negative indoxyl-ester-diazonium
Microscopic Examination
Pus Cells [In Urine] 1-2 /HPF 1 - 2 /HPF Flow Micro Imaging
Epithelial Cells (Squamous) 1-2 /HPF 0-2/HPF Flow Micro Imaging

Epithelial Cells (Non-Squamous) NIL /HPF 0-2/HPF Flow Micro Imaging


Urinary RBC NIL /HPF NIL /HPF Flow Micro Imaging
Hyaline Casts NIL /LPF 0-2/LPF Flow Micro Imaging
Pathological Casts NIL /LPF 0-1/LPF Flow Micro Imaging
Yeast Cells NIL /HPF 0-1/HPF Flow Micro Imaging
Crystals NIL /HPF NIL/HPF Flow Micro Imaging
Other Morphology NIL NIL Microscopy

-----------------------------------------------------------------------
Remarks on Sample Quantity: The Urine quantity is observed after transfer to a Urinalysis Vacutainer Tube for preservation of sample.
Microscopy: Microscopy may have supplemented automated measurements, wherever necessary.
-----------------------------------------------------------------------
Advise: Please correlate results clinically.
-----------------------------------------------------------------------

Scan to Validate

Page 5 of 8
B-52, Basement and Ground Floor, GT Karnal Road, Industrial Area, Delhi 110033
Patient Name : Ashish Chadha Lab No : GTK24092812
Age / Sex : 45 Y / M Registration On : 22-Sep-24 16:28
Referred By : Dr. JAGDEEP CHUGH Patient ID : UGTK.0000011692
Centre : ASHOK VIHAR

C-Reactive Protein Serum Sample

Accession No: CL02223742 Collected On: 22-Sep-24 16:28 Received On: 22-Sep-24 19:31 Approved On: 22-Sep-24 22:48
Observation Result Unit Biological Ref. Interval Method
Crp [Quantitative] 42 mg/L <5.0 Immunoturbidimetric

-------------------------------------------------------------------------------------------------------------------
Clinical Significance of CRP:
C-reactive protein (CRP) is a serum protein, which issynthesized in the liver. Its rate of synthesis and secretion increases within hours of an acute injury or the onset of inflammation
and may reach as high as 20 times the normal levels. Elevated serum concentration of CRP indicates active tissue damage process and CRP measurement thus provides a simple
screening test for organic disorders. Clinical Significance of CRP stands important for
- Inflammatory disorders
- Management of neonatal septicaemia and meningitis
- Postoperative surveillance
- Myocardial infarction
- CRP is found to be present after the first trimester of pregnancy and persists until delivery.
- CRP levels increase in women who are on oral contraceptives.
- CRP response is not affected by the commonly used anti-inflammatory or immunosuppressive drugs, including steroids, unless the disease activity is affected.
Advise for CRP:
Since CRP production is a non-specific response to tissue injury, it is recommended that results of the test should be correlated with clinical findings to arrive at the final diagnosis. In
cases where an increase in CRP levels is suspected, but the screening tests shows negative results, semiquantitation should be done to rule out prozone effect.
---------------------------------------------------------------------------------
Sample Type: Serum
Technology: VITROS MicroTip, MicroSensor & Intellicheck
Analyzer: Fully Automated Biochemistry and Immunology Analyzer : VITROS 5600
---------------------------------------------------------------------------------
Advise: Please correlate results with clinical conditions
---------------------------------------------------------------------------------

In case of any unexpected or alarming results, please contact us immediately for re-confirmation, clarifications, and rectifications, if needed.

Widal Serum Sample

Accession No: SE00295783 Collected On: 22-Sep-24 16:28 Received On: 22-Sep-24 19:31 Approved On: 22-Sep-24 21:00

Observation Result Unit Biological Ref. Interval Method


Salmonella Typhi O 1:40 Slide semi-Quantitative
Salmonella Typhi H 1:40 Slide semi-Quantitative
S.Paratyphi A H 1:20 Slide semi-Quantitative
S.Paratyphi B H 1:20 Slide semi-Quantitative

---------------------------------------------------------------------------------
Clinical Significance:
The Widal test is used to make a presumptive diagnosis of enteric fever or typhoid fever. This method relies on a reaction in a test-tube or on a slide between antibodies present in
the infected persons blood sample and specific antigens of Salmonella typhi (H and O), which produces visible clumping or agglutination.
- Antibody titres of 1:80 or more are considered dianostically significant. However, the significant titre may vary from between populations and needs ti be established for each area
.
- H agglutination is more reliable than O agglutinin.
- Agglutinin starts appearing in serum by the end of 1st week with sharp rise in 2nd and 3rd week and the titre remains steady till 4th week after which it declines.
---------------------------------------------------------------------------------
Limitations:
- The Widal test may be falsely positive in patients who have had previous vaccination or infection with S. Typhi.
- Besides cross-reactivity with other Salmonella species, the test cannot distinguish between a current infection and a previous infection or vaccination against typhoid.
- False positive Widal test results are also known to occur in typhus, acute falciparum malaria (particularly in children), chronic liver disease associated with raised globulin levels and
disorders such as rheumatoid arthritis, myelomatosis and nephrotic syndrome.
- False negative results may be associated with early treatment, with hidden organisms in bone and joints, and with relapses of typhoid fever. Occasionally, false negative results
may also be due to the infecting strains being poorly immunogenic, antibody responses being blocked by early antimicrobial treatment or following a typhoid relapse.
---------------------------------------------------------------------------------
Please correlate results with clinical condition.
---------------------------------------------------------------------------------

Scan to Validate

Page 6 of 8
B-52, Basement and Ground Floor, GT Karnal Road, Industrial Area, Delhi 110033
Patient Name : Ashish Chadha Lab No : GTK24092812
Age / Sex : 45 Y / M Registration On : 22-Sep-24 16:28
Referred By : Dr. JAGDEEP CHUGH Patient ID : UGTK.0000011692
Centre : ASHOK VIHAR

Dengue NS1 Serum Sample

Accession No: SE00295783 Collected On: 22-Sep-24 16:28 Received On: 22-Sep-24 19:31 Approved On: 22-Sep-24 21:00
Observation Result Unit Biological Ref. Interval Method

Dengue NS1 Antigen 0.12 Index Value <1:Negative CLIA


≥1:Positive

--------------------------------------------------------------------------------------------------
Interpretation:
Interpretation Remarks
Negative No detectable Dengue NS1. The result does not rule our dengue infection. An additional sample for IgG and IgM ishould be tested after 7-14 days.
Equivocal Repeat Sample after 1 Week
Positive Presence of detectable NS1 Antigen. Dengue IgG and IgM Assay Should Be Performed after 5-7 days of onset of fever, to confirm dengue infecton
--------------------------------------------------------------------------------------------------
Clinical Advise: For the first 5 days of fever, advised screening test is Dengue NS1 Antigen, After 7-10 of fever onset, the receommended screening test is Dengue IgG and IgM
Serology.
--------------------------------------------------------------------------------------------------
Advise: Please note that this is a screening test only. Advised confirmation with Dengue by PCR for further diagnosis.
--------------------------------------------------------------------------------------------------
Please correlate results clinically.
--------------------------------------------------------------------------------------------------

Chikungunya IgM Serum Sample

Accession No: SE00295783 Collected On: 22-Sep-24 16:28 Received On: 22-Sep-24 19:31 Approved On: 22-Sep-24 20:39
Observation Result Unit Biological Ref. Interval Method
Chikungunya IgM Negative Lateral flow immuno chromatography

--------------------------------------------------------------------------------------------------
Advise: Please note that this is a screening test. Advised confirmation with RT-PCR for Chikungunya.
--------------------------------------------------------------------------------------------------
Sample Type: Serum
--------------------------------------------------------------------------------------------------
Please correlate results clinically.
--------------------------------------------------------------------------------------------------

Malaria Antigen EDTA Whole Blood Sample

Accession No: SE00295784 Collected On: 22-Sep-24 16:28 Received On: 22-Sep-24 19:32 Approved On: 22-Sep-24 20:39

Observation Result Unit Biological Ref. Interval Method


Plasmodium Falciparum Negative Negative Immuno-chromatography
Plasmodium Vivax Negative Negative Immuno-chromatography

----------------------------------------------------------------------------
Clinical Notes: This test is used for the detection of antibodies of all isotypes against P. falciparum & P.vivax in blood samples. Species Specific
Serologic tests for malaria are particularly useful for epidemiolgic surveys and for detection of infected blood donors. Such tests do not reliably
differentiate current from past infection. A negative result does not rule out the possibility of malarial infection, as the antiboody may not develop
in the early stages of the disease.
---------------------------------------------------------------------------------
Sample Type: EDTA
---------------------------------------------------------------------------------
Please correlate results clinically.
---------------------------------------------------------------------------------

Typhidot IgM
Accession No: SE00295783 Collected On: 22-Sep-24 16:28 Received On: 22-Sep-24 19:31 Approved On: 22-Sep-24 20:39
Observation Result Unit Biological Ref. Interval Method
Typhi Dot (IgM) Negative Immunochromatography

Scan to Validate

Page 7 of 8
B-52, Basement and Ground Floor, GT Karnal Road, Industrial Area, Delhi 110033
Patient Name : Ashish Chadha Lab No : GTK24092812
Age / Sex : 45 Y / M Registration On : 22-Sep-24 16:28
Referred By : Dr. JAGDEEP CHUGH Patient ID : UGTK.0000011692
Centre : ASHOK VIHAR
-------------------------------------------------------------------------------------
Clinical Significance :-
(1) TyphiDot (IgM) measures recent infection.
(2) These tests are intended to be used as screening test. Positive test must be Confirmed with confirmatory testing method(s).
(3) Specimens containing unusually high titre of heterophile antibodies or RA factor may give false positive results.
(4) A negative result indicates absence of detectable antibodies. However, a negative test does not rule out S.Typhi.
-------------------------------------------------------------------------------------
Please correlate results clinically.
-------------------------------------------------------------------------------------

In case of any unexpected or alarming results, please contact us immediately for re-confirmation, clarifications, and rectifications, if needed.

Scan to Validate

Page 8 of 8
B-52, Basement and Ground Floor, GT Karnal Road, Industrial Area, Delhi 110033
Experience Care

Conditions Of Reporting
The report results are for information and interpretation for your referring doctor. Reports are to be
correlated with the patient’s clinical history.

Biological Reference Range/Interval is suggested for your Gender and Age on the basis of available
literature. All reference ranges are to be reconsidered by physician’s advice for your specific care.

This Medical Report is a professional opinion, not a diagnosis.

The report will carry the name and age provided at the time of registration. To maintain confidentiality,
certain reports may not be e-mailed at the discretion of the management.

All the notes and interpretation beneath the pathology result in the report provided are for educational
purpose only. It is not intended to be a substitute for physician's consultation.

Results of tests may vary from laboratory to laboratory and in some parameters from time to time for the
same patients. Test results and reference range may also vary depending on the technology and
methodology used. Laboratory test results may also vary depending on the age, sex, time of the day
sample has been taken, diet, medication and limitation of modern technology.

In case of any unexpected or alarming test results, please contact us immediately for re-confirmation,
further discussion, clarifications and rectifications, if needed.

In case of any discrepancy due to typing error, kindly get it rectified immediately.

Neither HOD or its employees/representatives assume any liability or responsibility for any loss or
damage that may be incurred by any person as a result of interpreting the meaning of this report.

Test results are not valid for medico legal purposes.

In case of any issues or suggestions about your test results, please email us on
[email protected]

The courts (forums) at Delhi shall have exclusive jurisdiction in all disputes/claims concerning the tests
and the results of the tests. Our liability is limited to the amount of investigations booked with us.

DOC#COR20200707

Facilities Available
Radiology Pathology Nuclear Medicine
3T MRI & 1.5T MRI Biochemistry India’s First Simultaneous PET-MRI
CT Scan Immunoassay Whole Body PET/CT Scan
Digital X-Ray Hematology DTPA / DMSA Renal Scans
Mammography Clinical Pathology Thyroid Scan
Open / Standing MRI Serology Whole Body Bone Scan
Bone DEXA Scan Microbiology HIDA Scan • Rest MUGA

Cardiology Investigations Neurology Investigations Dental Imaging


ECG (Electrocardiogram) EEG - ElectroEncephaloGram CBCT - Cone Beam CT Scan
Echocardiography EMG - ElectroMyoGraphy OPG - OrthoPantomoGram
TMT NCV - Nerve Conduction Velocity
Stress Echocardiography VEP - Visual Evoked Response Other Tests
Stress Thallium SSEP PFT

You might also like